These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group. Kessler CM; Ludlam CA Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193 [No Abstract] [Full Text] [Related]
3. Acquired hemophilia A: a rare but important challenge for the internist. Prisco D Ann Ital Med Int; 2005; 20(3):IV-V. PubMed ID: 16250180 [No Abstract] [Full Text] [Related]
4. [Acquired factor VIII hemophilia in a geriatric patient]. Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186 [TBL] [Abstract][Full Text] [Related]
5. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor. Mahasandana C; Suvatte V; Tanphaichitr VS; Bejrachandra S; Chandanayingyong D J Med Assoc Thai; 1988 Mar; 71(3):154-8. PubMed ID: 3133440 [No Abstract] [Full Text] [Related]
6. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Hauser I; Schneider B; Lechner K Thromb Haemost; 1995 Jan; 73(1):1-5. PubMed ID: 7740477 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors to factor VIII:C in nonhemophiliacs. Milica CD; Gradimir JM; Nada S; Radoje CB Am J Hematol; 1996 May; 52(1):61. PubMed ID: 8638615 [No Abstract] [Full Text] [Related]
9. Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy. Toepfer M; Rommel F; Sitter T; Spannagl M; Held E; Schramm W; Schiffl H Thromb Haemost; 1998 Dec; 80(6):1035-6. PubMed ID: 9869185 [No Abstract] [Full Text] [Related]
11. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature]. Bayani N; Lelong F Ann Med Interne (Paris); 2001 Apr; 152(3):201-8. PubMed ID: 11431582 [No Abstract] [Full Text] [Related]
12. Acquired hemophilia A: a concise review. Franchini M; Gandini G; Di Paolantonio T; Mariani G Am J Hematol; 2005 Sep; 80(1):55-63. PubMed ID: 16138334 [TBL] [Abstract][Full Text] [Related]
13. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature. Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199 [TBL] [Abstract][Full Text] [Related]
14. Evidence for antiphospholipid antibodies in hemophilic children with factor VIII inhibitors. Recombinate PUP Study Group. Nuss R; Jacobson L; Hathaway WE; Manco-Johnson M Thromb Haemost; 1999 Nov; 82(5):1559-60. PubMed ID: 10595659 [No Abstract] [Full Text] [Related]
15. The use of intravenous immunoglobulins in the treatment of factor VIII inhibitors. Sultan Y; Kazatchkine MD; Algiman M; Dietrich G; Nydegger U Semin Hematol; 1994 Apr; 31(2 Suppl 4):65-6. PubMed ID: 7939782 [No Abstract] [Full Text] [Related]
16. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppression of patients with acquired factor VIII inhibitors. Green D Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780 [No Abstract] [Full Text] [Related]
18. Solid tumors and factor VIII antibodies. Hauser I; Lechner K Thromb Haemost; 1999 Sep; 82(3):1005-7. PubMed ID: 10494753 [TBL] [Abstract][Full Text] [Related]
19. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols. Mariani G; Scheibel E; Nogao T; Kasper CK; Ewing NP; Mauser-Bunschoten E; Ghirardini A; Bellocco R; Brackman HH Semin Hematol; 1994 Apr; 31(2 Suppl 4):62-4. PubMed ID: 7939781 [No Abstract] [Full Text] [Related]
20. The effects of a comprehensive self-hypnosis training program on the use of factor VIII in severe hemophilia. Swirsky-Sacchetti T; Margolis CG Int J Clin Exp Hypn; 1986 Apr; 34(2):71-83. PubMed ID: 3084393 [No Abstract] [Full Text] [Related] [Next] [New Search]